Sabra Health Care REIT - SBRA Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SBRA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBRA, but not buy additional shares or sell existing shares.
View SBRA analyst ratings or view top-rated stocks.

10 Wall Street analysts have issued twelve-month price objectives for Sabra Health Care REIT's shares. Their SBRA share price forecasts range from $13.00 to $18.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 11.3% from the stock's current price.
View analysts price targets for SBRA or view top-rated stocks among Wall Street analysts.

Sabra Health Care REIT's stock was trading at $12.43 at the beginning of 2023. Since then, SBRA shares have increased by 8.4% and is now trading at $13.48.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 28th 2023.
View our SBRA earnings forecast.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced its quarterly earnings results on Wednesday, May, 4th. The real estate investment trust reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative net margin of 2.86% and a negative trailing twelve-month return on equity of 0.51%. During the same period last year, the firm earned $0.39 EPS.

Sabra Health Care REIT announced a quarterly dividend on Monday, November 7th. Investors of record on Thursday, November 17th will be given a dividend of $0.30 per share on Wednesday, November 30th. This represents a $1.20 dividend on an annualized basis and a yield of 8.90%. The ex-dividend date is Wednesday, November 16th.
Read our dividend analysis for SBRA.

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.92%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SBRA.

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

Sabra Health Care REIT's stock is owned by a number of institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (0.78%), Presima Securities ULC (0.42%), Wedge Capital Management L L P NC (0.28%), Gilman Hill Asset Management LLC (0.21%), Strs Ohio (0.19%) and Gateway Investment Advisers LLC (0.15%). Insiders that own company stock include Catherine Cusack, Harold W Jr Andrews, Michael J Foster, Michael J Foster and Robert A Ettl.
View institutional ownership trends.

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of SBRA stock can currently be purchased for approximately $13.48.

Sabra Health Care REIT (NASDAQ:SBRA) has a market capitalization of $3.11 billion and generates $569.54 million in revenue each year. The real estate investment trust earns $-113,260,000.00 in net income (profit) each year or ($0.08) on an earnings per share basis.

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The official website for the company is www.sabrahealth.com. The real estate investment trust can be reached via phone at (888) 393-8248, via email at investorrelations@sabrahealth.com, or via fax at 949-679-8868.